NCT05627674
Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment
Enrolling by Invitation
NAAges 18+InterventionalPreventionWashington University School of MedicineInvestigator-initiated
~915 participants
Updated 2025-12-24 on ClinicalTrials.gov
What's tested:Usual CareRiskProfile-ClinRiskProfile-Gen
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinician ordering of lung cancer screening
Measured over From enrollment through 6 months post-intervention
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesMissouri1
Study leadership
- Alex Ramsey, Ph.D. · PRINCIPAL_INVESTIGATOR · Washington University School of Medicine
- Li-Shiun Chen, M.D., MPH, ScD · PRINCIPAL_INVESTIGATOR · Washington University School of Medicine
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patient of participating primary care clinician
Lung cancer screening naïve
Between 50 to 80 years of age, inclusive
Current or former smokers
Pack years ≥ 20
English-speaking
Exclusion
Lung cancer diagnosis
Current order placed for lung cancer screening
What this trial measures
- Clinician ordering of lung cancer screeningFrom enrollment through 6 months post-intervention
This will be quantified by the proportion of screen-eligible patients who receive a clinician order for lung cancer screening.
- Patient completion of lung cancer screeningFrom enrollment through 6 months post-intervention
This will be quantified by the proportion of screen-eligible patients who complete lung cancer screening.